PL2869841T3 - Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy - Google Patents

Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy

Info

Publication number
PL2869841T3
PL2869841T3 PL13734111T PL13734111T PL2869841T3 PL 2869841 T3 PL2869841 T3 PL 2869841T3 PL 13734111 T PL13734111 T PL 13734111T PL 13734111 T PL13734111 T PL 13734111T PL 2869841 T3 PL2869841 T3 PL 2869841T3
Authority
PL
Poland
Prior art keywords
polynucleotides
polypeptides encoded
immunogenic polypeptides
regimens involving
boosting regimens
Prior art date
Application number
PL13734111T
Other languages
English (en)
Inventor
Alfredo Nicosia
Ricardo CORTESE
Alessandra Vitelli
Original Assignee
Glaxosmithkline Biologicals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52780606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2869841(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from PCT/EP2012/063196 external-priority patent/WO2014005643A1/en
Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa
Publication of PL2869841T3 publication Critical patent/PL2869841T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18511—Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18534—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
PL13734111T 2012-07-05 2013-07-05 Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy PL2869841T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/EP2012/063196 WO2014005643A1 (en) 2012-07-05 2012-07-05 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides
PCT/EP2013/064286 WO2014006191A1 (en) 2012-07-05 2013-07-05 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides
EP13734111.1A EP2869841B1 (en) 2012-07-05 2013-07-05 Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides

Publications (1)

Publication Number Publication Date
PL2869841T3 true PL2869841T3 (pl) 2022-01-24

Family

ID=52780606

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13734111T PL2869841T3 (pl) 2012-07-05 2013-07-05 Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy

Country Status (5)

Country Link
EP (2) EP3842068A1 (pl)
CY (1) CY1124712T1 (pl)
HR (1) HRP20211756T1 (pl)
PL (1) PL2869841T3 (pl)
SI (1) SI2869841T1 (pl)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180398B1 (en) 1996-07-12 2001-01-30 Virogeneitics Corporation Two-step immunization procedure against the pyramyxoviridae family of viruses using recombinant virus and subunit protein preparation
EP2163260B1 (en) 2004-01-23 2017-03-15 MSD Italia S.r.l. Chimpanzee adenovirus vaccine carriers
EP2104681A4 (en) * 2007-01-05 2011-01-19 Inseron Inc OPTIMIZED GREEN FLUORESCENT PROTEIN FOR EXPRESSION OF SELF-COLDING POLYPEPTIDES
WO2009025770A2 (en) * 2007-08-17 2009-02-26 Wyeth A heterologous prime-boost immunization regimen
GB0823497D0 (en) * 2008-12-24 2009-01-28 Isis Innovation Immunogenic composition and use thereof
EP3385387B1 (en) 2009-02-02 2021-08-25 GlaxoSmithKline Biologicals SA Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
WO2012021730A2 (en) * 2010-08-11 2012-02-16 Genvec, Inc. Respiratory syncytial virus (rsv) vaccine
WO2012085936A2 (en) * 2010-12-20 2012-06-28 Panacea Biotech Ltd Recombinant respiratory syncytial virus plasmids and vaccines
WO2012089231A1 (en) 2010-12-30 2012-07-05 Okairòs Ag Paramyxovirus vaccines
CN105431169B (zh) 2012-03-22 2019-04-02 扬森疫苗与预防公司 抗rsv疫苗

Also Published As

Publication number Publication date
HRP20211756T1 (hr) 2022-02-18
CY1124712T1 (el) 2022-07-22
EP2869841B1 (en) 2021-08-25
EP2869841A1 (en) 2015-05-13
SI2869841T1 (sl) 2022-02-28
EP3842068A1 (en) 2021-06-30

Similar Documents

Publication Publication Date Title
ZA201500102B (en) Novel prime-boosting regimens involving immunogenic polypeptides encoded by polynucleotides
IL291571A (en) cx3cr1 binding polypeptides
EP2834259A4 (en) MODIFIED POLYNUCLEOTIDES
SG11201503741UA (en) Two-dimensional code
PL2928489T3 (pl) Kompozycja immunogenna
GB201220474D0 (en) Polypeptides
HUE040914T4 (hu) Immunogén készítmény
IL238079A0 (en) Immunogenic preparation
SG11201503742XA (en) Two-dimensional code
GB201223342D0 (en) Immunogenic composition
EP2848291A4 (en) GYRO
DK2941162T3 (en) Formeapparat til formet gulv
ZA201501562B (en) Treatment regimens
PL2869841T3 (pl) Nowe schematy prime-boost wykorzystujące polipeptydy immunogenne kodowane przez polinukleotydy
GB201210900D0 (en) Movable platforms
TWM433222U (en) Multifunctional hair-decoration swimming cap
GB201219944D0 (en) Water-powered motor
GB201213753D0 (en) Angle
GB201202102D0 (en) Indu-green energy bio-sustainable project
GB201219337D0 (en) Garrods movement
AU347500S (en) Top
AU347499S (en) Top
AU347497S (en) Top
AU346943S (en) Top
AU346940S (en) Top